In a time of increasingly individualized healthcare, Elizabeth Philp has emerged as a formidable figure of innovation, particularly in the tech-driven field of compounded pharmacy. As the chief executive and co-founder of Roseway Labs, Philp is at the forefront of a movement to make tailor-made medications more available, challenging the standard